156 related articles for article (PubMed ID: 15017656)
1. Fecal multiple molecular tests to detect colorectal cancer in stool.
Calistri D; Rengucci C; Bocchini R; Saragoni L; Zoli W; Amadori D
Clin Gastroenterol Hepatol; 2003 Sep; 1(5):377-83. PubMed ID: 15017656
[TBL] [Abstract][Full Text] [Related]
2. Multiple detection of genetic alterations in tumors and stool.
Rengucci C; Maiolo P; Saragoni L; Zoli W; Amadori D; Calistri D
Clin Cancer Res; 2001 Mar; 7(3):590-3. PubMed ID: 11297253
[TBL] [Abstract][Full Text] [Related]
3. DNA alterations of microsatellite DNA, p53, APC and K-ras in Chinese colorectal cancer patients.
Xu XM; Qian JC; Cai Z; Tang T; Wang P; Zhang KH; Deng ZL; Cai JP
Eur J Clin Invest; 2012 Jul; 42(7):751-9. PubMed ID: 22324744
[TBL] [Abstract][Full Text] [Related]
4. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
5. Detecting colorectal cancer in stool with the use of multiple genetic targets.
Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.
Tagore KS; Lawson MJ; Yucaitis JA; Gage R; Orr T; Shuber AP; Ross ME
Clin Colorectal Cancer; 2003 May; 3(1):47-53. PubMed ID: 12777192
[TBL] [Abstract][Full Text] [Related]
7. [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening].
Zhan J; Li X; Yu Z; Yuan YH; Hou J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1018-21. PubMed ID: 17666342
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
[TBL] [Abstract][Full Text] [Related]
9. Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.
Chiang JM; Wu Chou YH; Ma SC; Chen JR
Virchows Arch; 2004 Nov; 445(5):465-71. PubMed ID: 15449054
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer-associated DNA mutations: marker selection for the detection of proximal colon cancer.
Berger BM; Robison L; Glickman J
Diagn Mol Pathol; 2003 Dec; 12(4):187-92. PubMed ID: 14639104
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite analysis of fecal DNA for colorectal cancer detection.
Koshiji M; Yonekura Y; Saito T; Yoshioka K
J Surg Oncol; 2002 May; 80(1):34-40. PubMed ID: 11967905
[TBL] [Abstract][Full Text] [Related]
12. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.
Eguchi S; Kohara N; Komuta K; Kanematsu T
Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566
[TBL] [Abstract][Full Text] [Related]
14. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
15. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.
Jeon CH; Lee HI; Shin IH; Park JW
Int J Colorectal Dis; 2008 Jan; 23(1):29-35. PubMed ID: 17704924
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
19. The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients.
Wang JY; Hsieh JS; Lu CY; Yu FJ; Wu JY; Chen FM; Huang CJ; Lin SR
Hepatogastroenterology; 2007 Dec; 54(80):2259-65. PubMed ID: 18265644
[TBL] [Abstract][Full Text] [Related]
20. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
